Cutler Group’s Aceragen Inc ACGN Stock Holding History

Cutler Group’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47	Closed	-$2K	–	6386
2021 Q3	$2K	Buy	+47	New	+$848	﹤0.01%	5165

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's ACGN Position: Q1 2022 in Review

Cutler Group sold out of Aceragen Inc (ACGN) in Q1 2022, closing a stake of 77 shares.

Cutler Group first reported a position in ACGN in Q4 2015 and held it in 14 quarters. The position peaked at $46K in Q1 2017. 31 funds tracked by Wall St. Rank hold ACGN as of Q1 2022.

Cutler Group reported no remaining Aceragen Inc position as of Q1 2022 after selling out during the quarter.
Cutler Group sold 77 Aceragen Inc shares in Q1 2022.
Cutler Group first reported a position in Aceragen Inc in Q4 2015 and held it in 14 quarters.
Cutler Group's Aceragen Inc position peaked at $46K in Q1 2017.
31 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.